Proteomic Analysis on Multi-Drug Resistant Cells HL-60/DOX of Acute Myeloblastic Leukemia

Chun-Yan Chen；Ji-Hui Jia；Mao-Xiu Zhang；Yue-Sheng Meng；De-Xiao Kong；Xiang-Lin Pan；Xiu-Ping Yu

leukemia ； myeloblastic ； multi-drug resistance ； proteomics

The Chinese Journal of Physiology

48卷3期（2005 / 09 / 30）

115 - 120

英文

Multi-drug resistance (MDR) is an important factor that causes treatment failure in acute leukemia. However, the full development mechanisms of MDR still awaits investigation. The purpose of this study is to investigate differentially expressed proteins in the multi-drug resistant acute myeloblastic leukemia (AML) cell line HL-60/DOX and the drug sensitive cell line HL-60, and to identify new potential multi-drug resistant related molecules with the proteomic approach. Two-dimensional gel electrophoresis (2-DE) maps of the proteins, extracted from two AML cell lines, HL-60/DOX and HL60, were established respectively. The extracted proteins were digested by enzymes and identified with the matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The data of the peptide mass fingerprinting (PMF) was matched with databases of proteomics available on the Internet. Results showed that 16 proteins were identified to be differentially expressed between HL-60/DOX and HL-60 cells. They involved the protein disulfide isomerase precursor (PDI), the proteasomes α1 and other proteins which are related to drug resistance or cell metabolism, but their functional significances are required further investigation. Nevertheless, it is clear that this proteomic approach for studing the biology and development of MDR is a prerequisite in leukemia.

1. Gong, Y.P.,Liu, T.,Jia, Y.Q.,Qin, L.,Deng, C.Q.,Yang, R.Y.(2002).Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines.Int. J. Hematol,75,154-160.
   連結：
2. Baker, E.K.,EI-Ota. A.(2003).The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.Exp. Cell Res.,290,177-194.
3. Chen. G.,Gharib, T.G.,Huang, C.C.,Thomas, D.G.,Shedden, K.A.,Taylor, J.M.,Kardia, S.L.,Misek, D.E.,Giordano, T.J.,Iannettoni, M.D.,Orringer, M.B.,Hanash, S.M.,Beer, D.G.(2002).Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.Clin. Cancer Res.,8,2298-2305.
4. Cress, A.E.,Dalton, W.S.(1996).Multiple drug resistance and intermediate filaments.Cancer Metast. Rev.,15,499-506.
5. Fanelli, M.,Minucci, S.,Gelmetti, V.,Nervi, C.,Gambacorti-Passerini, C.,Pelicci, P.G.(1999).Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance.Blood,93,1477-1481.
6. Foresman, M.D.,Nelson, D.M.,McIvor, R.S.(1992).Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency.Hum. Gene. Ther.,3,625-631.
7. Greasley, S.E.,Horton P.,Ramcharan J.,Beardsley G.P.,Benkovic S.J.,Wilson I.A.(2001).Crystal structure of a bifunctional transformylase and cyclohydrolase enzyme in purine biosynthesis.Nat. Struct. Biol,8,402-406.
8. Hasegawa. K.,Wang, Z.,Inagaki, M.,Carr. B.l.(1995).Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta I (TGF-beta I).In Vitro Cell Des`, Biol. Anim.,31,55-31.
9. Hirose, M.,Hosoi, E.,Hamano, S.,Jalili. A.(2003).Multidrug resistance in hematological malignancy.J. Med. Inrest.,50,126-135.
10. Hutter, G.,Sinha, P.(2001).Proteomics for studying cancer cells and the development of chemoresistance.Proteomics,1,1233-1248.
11. Kalinina, E.V.,Saprin, A.N.,Solomka, V.S.,Shcherbak, N.P.,Chermnykh, N.S.,Piruzian, L.A.(2001).Role of the antioxidant system and redox-dependent regulation of transcription factors bcl-2 and p53 in forming resistance of human K562 erythroleukemia cells to doxorubicin.Vopr. Onkol,47,596-600.
12. Kappelmayer, J.,Simon, A.,Kiss, F.,Hevessy, Z.(2004).Progress in defining multidrug resistance in leukemia.Expert. Rev. Mol. Diagn,4,209-217.
13. Katoh, M.(2003).Expression and regulation of WNTI in human cancer: up-regulation of WNTI by beta-estradiol in MCF-7 cells.Int. J. Oncol,22,209-212.
14. Khan, J.(2003).Genomic & proteomic technological advances in cancer research.Pharmacogenomics,4,245-249.
15. Kozma, R.,Ahmed, S.,Best, A.,Lim, L.,Kozma, R.,Ahmed, S.,Best. A.,Lim, L.(1996).The GTPase-activating protein n-chimaerin cooperates with Rae I and Cdc42Hs to induce the formation of lamellipodia and filopodia.Mol. Cell Biol,16,5069-5080.
16. Leonard, G.D.,Fojo, T.,Bates, S.E.(2003).The role of ABC transporters in clinical practice.Oncologist,8,411-424.
17. Motoji, T.,Motomura, S.,Wang, Y.H.(2000).Multidrug resistance of acute leukemia and a strategy to overcome it.Int. J. Hematol,72,418-424.
18. Okamoto, P.M.,Gamby, C.,Wells, D.,Fallon, J.,Vallee, R.B.(2001).Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton.J. Biol. Chem,276,48458-48465.
19. Pilch, B.,Allemand, E.,Facompre, M.,Bailly, C.,Riou, J.F.,Soret, J.,Tazi, J.(2001).Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.Cancer Res.,61,6876-6884.
20. Plasschaert, S.L.,Van Der Kolk,D.M., De Bont,E.S. Vellenga,E., Kamps, WA.,De Vries. E.G.(2004).Breast cancer resistance protein (BCRP) in acute leukemia.Leuk. Lymphoma,45,649-654.
21. Poland, J.,Schadendorf, D.,Lage, H.,Schnolzer, M.,Celis, J.E.,Sinha, P.(2002).Study of therapy resistance in cancer cells with functional proteome analysis.Clin. Chem. Lab Med.,40,221-234.
22. Sinha, P.,Poland, J.,Kohl, S.,Schnolzer, M.,Helmbach, H.,Hutter, G.,Lage, H.,Schadendorf, D.(2003).Study of the development of chemoresistance in melanoma cell lines using proteome analysis.Electrophoresis,24,2386-2404.
23. Spataro, V.,Simmen, K.,Realini, C.A.(2002).The essential 26S proteasome subunit Rpn11 confers multidrug resistance to mammalian cells.Anticancer Res.,22,3905-3909.
24. Tager, M.,Kroning, H.,Thiel, U.,Ansorge, S.(1997).Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.Exp. Hematol,25,601-607.
25. Tsangaris, G.T.,Vamvoukakis, J.,Politis, I.,Kattamis, A.C.,Tzortzatou-Stathopoulou, F.(2000).Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia.Anticancer Res.,20,4407-4411.

1. Zhou, Ya-Bin,Zhang, Rong-Mei,Zhang, Mao-Xiu,Yu, Xiu-Ping,Jia, Ji-Hui,Chen, Chun-Yan(2006).Comparative Proteomics of Apoptosis Initiation Induced by 5-Fluorouracil in Human Gastric Cancer.Chinese Journal of Physiology,49(1),31-38.